For citations:
Borodavina E.V., Kutukova S.I., Kekeeva Т.V., Isaev Р.A. Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review). Head and Neck Tumors (HNT). 2025;15(1):74-88. (In Russ.) https://doi.org/10.17650/2222-1468-2025-15-1-74-88
Email this article 